I

IMMvention Therapeutix, Inc.

14 employees

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Immunology
Inflammasomes
Cytokines
Therapeutics
Inflammation

Date founded

2017

Funding rounds raised

Total raised

$250K

from 1 investors over 1 rounds

I

IMMvention Therapeutix, Inc. raised $250K on October 16, 2019

Investors: North Carolina Biotechnology Center (NCBiotech)

FAQ